MiR-92b and miR-9/9* are specifically expressed in brain primary tumors and can be used to differentiate primary from metastatic brain tumors
about
MicroRNA-driven developmental remodeling in the brain distinguishes humans from other primatesmiR-9, a MYC/MYCN-activated microRNA, regulates E-cadherin and cancer metastasis.Accurate molecular classification of renal tumors using microRNA expressionSignificance and therapeutic value of miRNAs in embryonal neural tumorsmiRNA-mRNA integrated analysis reveals roles for miRNAs in primary breast tumorsA Uniform System for the Annotation of Vertebrate microRNA Genes and the Evolution of the Human microRNAome.MiR-218 inhibits invasion and metastasis of gastric cancer by targeting the Robo1 receptor.MicroRNA-9 plays a role in interleukin-10-mediated expression of E-cadherin in acute myelogenous leukemia cellsMiR-92b inhibitor promoted glioma cell apoptosis via targeting DKK3 and blocking the Wnt/beta-catenin signaling pathwayMicroRNA genes derived from repetitive elements and expanded by segmental duplication events in mammalian genomes.MicroRNA-9 expression is a prognostic biomarker in patients with osteosarcoma.MicroRNAs in neural cell differentiationMicroRNA-218 is upregulated in gastric cancer after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy and increases chemosensitivity to cisplatinIdentification and developmental profiling of conserved and novel microRNAs in Manduca sextamiRNAs expression analysis in paired fresh/frozen and dissected formalin fixed and paraffin embedded glioblastoma using real-time pCR.Surprisal analysis of Glioblastoma Multiform (GBM) microRNA dynamics unveils tumor specific phenotype.miR-9 regulation of BRCA1 and ovarian cancer sensitivity to cisplatin and PARP inhibition.microRNA-9 suppresses the proliferation, invasion and metastasis of gastric cancer cells through targeting cyclin D1 and Ets1.MicroRNA signatures as biomarkers and therapeutic target for CNS embryonal tumors: the pros and the cons.Novel microRNA-based assay demonstrates 92% agreement with diagnosis based on clinicopathologic and management data in a cohort of patients with carcinoma of unknown primaryMicroRNA-9 promotes tumor metastasis via repressing E-cadherin in esophageal squamous cell carcinoma.MicroRNA-27a distinguishes glioblastoma multiforme from diffuse and anaplastic astrocytomas and has prognostic valueMicroRNA-9 as a novel prognostic biomarker in human laryngeal squamous cell carcinoma.MicroRNAs as potential clinical biomarkers: emerging approaches for their detection.In situ hybridization is a necessary experimental complement to microRNA (miRNA) expression profiling in the human brainCAMTA1 is a novel tumour suppressor regulated by miR-9/9* in glioblastoma stem cellsMicroRNAs as a potential prognostic factor in gastric cancer.miR-23b targets proline oxidase, a novel tumor suppressor protein in renal cancerMicroRNA-9: functional evolution of a conserved small regulatory RNA.MicroRNA-30e* promotes human glioma cell invasiveness in an orthotopic xenotransplantation model by disrupting the NF-κB/IκBα negative feedback loop.Methylation of microRNA-9 is a specific and sensitive biomarker for oral and oropharyngeal squamous cell carcinomas.MicroRNAs in cerebrospinal fluid identify glioblastoma and metastatic brain cancers and reflect disease activity.A second-generation microRNA-based assay for diagnosing tumor tissue origin.Comparative miRNAome analysis revealed different miRNA expression profiles in bovine sera and exosomes.MicroRNA-9 inhibition of cell proliferation and identification of novel miR-9 targets by transcriptome profiling in breast cancer cells.How interacting pathways are regulated by miRNAs in breast cancer subtypes.Oncogenic miR-9 is a target of erlotinib in NSCLCsInnovative therapeutic strategies in the treatment of brain metastases.Critical role of miR-9 in myelopoiesis and EVI1-induced leukemogenesisFunctional regulation of FoxO1 in neural stem cell differentiation
P2860
Q21145751-114DAD9F-3C4A-4617-9A8E-53FE5A04E6F0Q24613599-CCC7673B-D08D-4229-B01E-72C40CF8B928Q24625843-C0F5B4B8-1955-4695-9344-9E9FF6DF0FABQ26827171-A3092F4F-9695-40F5-9B84-D39EB8FBE3DCQ28742532-4233B789-1C59-4BFF-8F62-992081CBF87EQ30488426-ED2935D6-1B52-4476-BFA8-9DA5AEAD2222Q33543185-D8ED867B-464B-49E5-884A-7A1DA9585DECQ33607590-6F2434E6-BCBC-457C-8AAA-CA7405F22587Q33641219-F714D1B9-BF85-448D-89CE-DA159C11708AQ33855406-80C693C5-5046-4FCF-813C-425C37149836Q33857405-0CB8268A-575A-4296-849A-02A32F2D7E90Q33905890-EBEACDCA-D6C9-4115-BEBE-662555AE00E4Q34093885-3AE0C77E-01B7-492B-B0E7-4A1007490B9FQ34190625-D2799C1D-AED1-4D81-AD00-99C9FD8D0818Q34243937-967517B7-E9F5-4AB0-9325-A07F42E35879Q34268806-C4BB7DD7-F7D7-4E06-A0BF-836EDA2C833DQ34380980-F279779E-F86A-4816-9402-436BEEAFDB83Q34576919-FDEE11BC-3713-48BB-9F8D-A54DEDF77181Q34685896-00CB7761-B3B7-4F1F-8FF0-4A27A949BED7Q34768554-8B279D29-B377-4FC1-8C29-AA5A850CCB19Q34956599-682BB374-E369-4421-AE12-E6B356EEA4ADQ34991208-EA201752-B192-4737-8234-4F4FA39F8B30Q35017255-4AA6E4D8-1266-4F30-BC49-59D5EADA24E8Q35053672-72FA99D4-CBD6-4364-A046-AD31227453CDQ35208140-5CD4C6D7-E76C-4726-87E1-4A3ECD8C1585Q35422357-0A0D4C70-C6C2-48C5-8E0A-26D54D121208Q35424564-0790F88E-9E52-4592-B0D7-6EF679789A77Q35438578-5E6A620D-94DF-4960-8B24-D5D7416C9C96Q35578530-34B4C15D-5127-4519-B074-5D85637E8566Q35640588-9196C531-9A88-43E6-B8A5-4B47C8C528B9Q35792884-3675181B-92FC-44E6-881E-B61622CA08F3Q36010084-B0E701DD-F29F-4ED1-91EF-1DC0DAB0D915Q36051505-BDBA1FBE-C2C5-4C89-9A72-B2EC56C77AFDQ36103173-69F39CB2-925E-4DAC-A1A4-BD01DF3ADAA1Q36215852-78C760BE-AC0A-4343-877B-D2DF293A6A5AQ36276533-9BE11776-4289-43A9-9EB5-D3D6B75844F1Q36305862-4D191355-41FB-4F3C-B042-2F10D3030A12Q36590195-0F108667-C791-49D1-A91A-DC2BC8F96807Q36747434-D5CB2399-7A0E-438C-B3C3-1ADF82920A19Q36751515-14D29306-3962-4823-B93B-2FAEEDFC65B1
P2860
MiR-92b and miR-9/9* are specifically expressed in brain primary tumors and can be used to differentiate primary from metastatic brain tumors
description
2009 nî lūn-bûn
@nan
2009 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
MiR-92b and miR-9/9* are speci ...... y from metastatic brain tumors
@ast
MiR-92b and miR-9/9* are speci ...... y from metastatic brain tumors
@en
MiR-92b and miR-9/9* are speci ...... y from metastatic brain tumors
@nl
type
label
MiR-92b and miR-9/9* are speci ...... y from metastatic brain tumors
@ast
MiR-92b and miR-9/9* are speci ...... y from metastatic brain tumors
@en
MiR-92b and miR-9/9* are speci ...... y from metastatic brain tumors
@nl
prefLabel
MiR-92b and miR-9/9* are speci ...... y from metastatic brain tumors
@ast
MiR-92b and miR-9/9* are speci ...... y from metastatic brain tumors
@en
MiR-92b and miR-9/9* are speci ...... y from metastatic brain tumors
@nl
P2093
P2860
P3181
P1433
P1476
MiR-92b and miR-9/9* are speci ...... y from metastatic brain tumors
@en
P2093
Anat Schlosberg
Dvora Nass
Einat Sitbon
Eran Elyakim
Gila Lithwick Yanai
Hadas Gibori
Hagit Kuker
Hila Cholakh
P2860
P304
P3181
P356
10.1111/J.1750-3639.2008.00184.X
P407
P577
2009-07-01T00:00:00Z